13 terminated. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Terminated 13 |
Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OnabotulinumtoxinA Bladder Injection Study OnabotulinumtoxinA 100Unit Injection - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Terminated | Corewell Health East | 6 | 2018-08-08 | 2022-02-10 |
| Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection Periprocedural Antibiotics, Extended Antibiotics, Injection of OnabotulinumtoxinA (BTX-A) - Overactive Bladder, Urinary Tract Infections | Phase 4 | Terminated | Vanderbilt University Medical Center | 22 | 2018-07-01 | 2023-11-02 |
| Fesoterodine on Urgency Episodes in Parkinson's Disease Population Fesoterodine, Placebo - Urinary Bladder, Overactive, Parkinson Disease | Phase 4 | Terminated | Sir Mortimer B. Davis - Jewish General Hospital | 5 | 2016-09-01 | 2019-09-26 |
| Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms Belladonna and Opium Suppository, Rectal Exam - Overactive Bladder | Phase 4 | Terminated | Campbell Grant | 23 | 2016-03-01 | 2019-02-20 |
| VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate Solifenacin succinate, Placebo - Over-Active Bladder | Phase 4 | Terminated | Advanced Research Network | 8 | 2013-02-01 | 2015-01-16 |
| Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder PTNS plus solifenacin, Placebo - Overactive Bladder | Phase 4 | Terminated | Bay State Clinical Trials, Inc. | 8 | 2013-01-01 | 2014-05-23 |
| Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate Fesoterodine fumarate, Placebo, Percutaneous Tibial Nerve Stimulation (PTNS) - Overactive Bladder | Phase 4 | Terminated | Mayo Clinic | 4 | 2012-06-01 | 2014-02-05 |
| Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder Tolterodine ER, Placebo - Overactive Bladder | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 18 | 2011-03-01 | 2021-01-28 |
| Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Baclofen, Placebo - Overactive Bladder, Constipation | Phase 4 | Terminated | Wake Forest University Health Sciences | 12 | 2009-09-01 | 2018-08-14 |
| Tetra-NIRS Clinical Study Urodynamics + TETRA - NIRS - Lower Urinary Tract Symptoms, Overactive Bladder | Phase 4 | Terminated | Laborie Medical Technologies Inc. | 155 | 2009-04-01 | 2016-07-19 |
| Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity Oxybutinin Extended-Release - Detrusor Function, Overactive | Phase 4 | Terminated | Janssen-Cilag Ltd.,Thailand | 17 | 2008-12-01 | 2013-11-26 |
| Feasibility of "At-home" Titration of Solifenacin Solifenacin - Overactive Bladder | Phase 4 | Terminated | NYU Langone Health | 36 | 2008-09-01 | 2015-10-26 |
| A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause. tolterodine - Urinary Incontinence | Phase 4 | Terminated | Brigham and Women's Hospital | 19 | 2006-04-01 | 2018-03-29 |
Urinary Incontinence (3) · Lower Urinary Tract Symptoms (2) · Constipation (1) · Nocturia (1) · Parkinson Disease (1) · Sleep Wake Disorders (1) · Urinary Tract Infections (1) · Urination Disorders (1)
Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Male Urogenital Diseases (13) · Pathological Conditions, Signs and Symptoms (13) · Signs and Symptoms (13) · Urinary Bladder Diseases (13) · Urogenital Diseases (13) · Urologic Diseases (13) · Urological Manifestations (13) · Lower Urinary Tract Symptoms (11) · Urination Disorders (3) · Nervous System Diseases (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1)
Solifenacin Succinate (3) · Tolterodine Tartrate (2) · fesoterodine (2) · Baclofen (1) · Botulinum Toxins, Type A (1) · Sugars (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
Advanced Research Network (1) · Bay State Clinical Trials, Inc. (1) · Brigham and Women's Hospital (1) · Campbell Grant (1) · Corewell Health East (1) · Janssen-Cilag Ltd.,Thailand (1) · Laborie Medical Technologies Inc. (1) · Mayo Clinic (1) · NYU Langone Health (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Sir Mortimer B. Davis - Jewish General Hospital (1) · Vanderbilt University Medical Center (1) · Wake Forest University Health Sciences (1)
United States (10) · Canada (2) · Thailand (1) · United Kingdom (1)
Gopal Badlani, MD (1) · H. David Mitcheson, MD (1) · Jeffrey Cornella, MD (1) · Larry Sirls, MD (1) · Lysanne Campeau, MD, PhD (1) · Melissa Kaufman, MD, PhD (1) · Patrick Mufarrij (1) · Quentin R Regestein, M.D. (1) · Sanjay Mehta, M.D. (1) · Sender Herschorn, MD (1)